Your account is not claimed yet. You can sign up with ORCID to claim your account.

Bin Yu

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 21

Top Venues

Journal of medicinal chemistry

Organic letters

Future medicinal chemistry

Medicinal research reviews

Zhengzhou University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Zhengzhou University Dec 1o 2016

China

Professor :: School of Pharmaceutical Sciences

Publications

Jingya Zhang, Wenshuo Gao, Yixia Wang, Jun-Biao Chang, Bin Yu
Targeted covalent inhibitors for novel therapeutics. Future medicinal chemistry (2023)
Yihui Song, Shu Wang, Bin Yu
Structural and Functional Landscape of FAD-Dependent Histone Lysine Demethylases for New Drug Discovery. Journal of medicinal chemistry (2022)
Guan-Jun Dong, Jiahui Zuo, Junlin Yu, Jiale Xu, Ge Gao, Guo-Bo Li, Wen Zhao, Bin Yu
Structure-Based Design of the Indole-Substituted Triazolopyrimidines as New EED-H3K27me3 Inhibitors for the Treatment of Lymphoma. Journal of medicinal chemistry (2022)
Yihui Song, Shu Wang, Bin Yu
Structural and Functional Landscape of FAD-Dependent Histone Lysine Demethylases for New Drug Discovery. Journal of medicinal chemistry 66 (1) (2022)
Kai Tang, Le-Min Jiao, Yu-Ruo Qi, Tian-Ci Wang, Ya-Lan Li, Jia-Le Xu, Zi-Wei Wang, Bin Yu, Hong-Min Liu, Wen Zhao
Discovery of Novel Pyrazole-Based KDM5B Inhibitor TK - 129 and Its Protective Effects on Myocardial Remodeling and Fibrosis. Journal of medicinal chemistry 65 (19) (2022)
Guan-Jun Dong, Jiahui Zuo, Junlin Yu, Jiale Xu, Ge Gao, Guo-Bo Li, Wen Zhao, Bin Yu
Structure-Based Design of the Indole-Substituted Triazolopyrimidines as New EED-H3K27me3 Inhibitors for the Treatment of Lymphoma. Journal of medicinal chemistry 66 (1) (2022)
Yihui Song, Shu Wang, Min Zhao, Xinyu Yang, Bin Yu
Strategies Targeting Protein Tyrosine Phosphatase SHP2 for Cancer Therapy. Journal of medicinal chemistry 65 (4) (2022)
Yihui Song, Shu Wang, Bin Yu
Structural and Functional Landscape of FAD-Dependent Histone Lysine Demethylases for New Drug Discovery. Journal of medicinal chemistry 66 (1) (2022)
Guan-Jun Dong, Jiahui Zuo, Junlin Yu, Jiale Xu, Ge Gao, Guo-Bo Li, Wen Zhao, Bin Yu
Structure-Based Design of the Indole-Substituted Triazolopyrimidines as New EED-H3K27me3 Inhibitors for the Treatment of Lymphoma. Journal of medicinal chemistry 66 (1) (2022)
Yihui Song, Shu Wang, Bin Yu
Structural and Functional Landscape of FAD-Dependent Histone Lysine Demethylases for New Drug Discovery. Journal of medicinal chemistry 66 (1) (2022)
Huiqing Zhang, Xinyu Yang, Yihui Song, Bin Yu
Combining EGFR inhibitors with SHP2 or LSD1 inhibitors to overcome multidrug resistance in cancer. Future medicinal chemistry 14 (8) (2022)
Guan-Jun Dong, Jiahui Zuo, Junlin Yu, Jiale Xu, Ge Gao, Guo-Bo Li, Wen Zhao, Bin Yu
Structure-Based Design of the Indole-Substituted Triazolopyrimidines as New EED-H3K27me3 Inhibitors for the Treatment of Lymphoma. Journal of medicinal chemistry 66 (1) (2022)
Yihui Song, Xinyu Yang, Shu Wang, Min Zhao, Bin Yu
Crystallographic landscape of SHP2 provides molecular insights for SHP2 targeted drug discovery. Medicinal research reviews 42 (5) (2022)
Shuai Wang, Sai-Qi Wang, Qiu-Xu Teng, Zi-Ning Lei, Zhe-Sheng Chen, Xiao-Bing Chen, Hong-Min Liu, Bin Yu
Discovery of the Triazolo[1,5-a]Pyrimidine-Based Derivative WS-898 as a Highly Efficacious and Orally Bioavailable ABCB1 Inhibitor Capable of Overcoming Multidrug Resistance. Journal of medicinal chemistry 64 (21) (2021)
Shuo Yuan, Jingya Zhang, Danqing Zhang, Dong-Hui Wei, Jiahui Zuo, Jian Song, Bin Yu, Hong-Min Liu
Cu(OTf)2-Catalyzed Intramolecular Radical Cascade Reactions for the Diversity-Oriented Synthesis of Quinoline-Annulated Polyheterocyclic Frameworks. Organic letters 23 (4) (2021)
Shuo Yuan, Bo Wang, Qing-Qing Dai, Xiao-Nan Zhang, Jing-Ya Zhang, Jia-Hui Zuo, Hui Liu, Zhe-Sheng Chen, Guo-Bo Li, Shaomeng Wang, Hong-Min Liu, Bin Yu
Discovery of New 4-Indolyl Quinazoline Derivatives as Highly Potent and Orally Bioavailable P-Glycoprotein Inhibitors. Journal of medicinal chemistry 64 (19) (2021)
Kai Tang, Ya-Hong Wu, Yihui Song, Bin Yu
Indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors in clinical trials for cancer immunotherapy. Journal of hematology & oncology 14 (1) (2021)
Shuo Yuan, Dan-Qing Zhang, Jing-Ya Zhang, Bin Yu, Hong-Min Liu
Palladium-Catalyzed Ligand-Free Double Cyclization Reactions for the Synthesis of 3-(1'-Indolyl)-phthalides. Organic letters 22 (3) (2020)
Sixi Wang, Bin Yu, Hong-Min Liu
Pd(II)-Catalyzed Intramolecular C(sp2)-H Arylation of Tryptamines Using the Nonsteric NH2 as a Directing Group. Organic letters 23 (1) (2020)
Shuo Yuan, Junbiao Chang, Bin Yu
Construction of Biologically Important Biaryl Scaffolds through Direct C-H Bond Activation: Advances and Prospects. Topics in current chemistry (Cham) 378 (2) (2020)
Shuai Wang, Sai-Qi Wang, Qiu-Xu Teng, Linlin Yang, Zi-Ning Lei, Xiao-Han Yuan, Jun-Feng Huo, Xiao-Bing Chen, Mengru Wang, Bin Yu, Zhe-Sheng Chen, Hong-Min Liu
Structure-Based Design, Synthesis, and Biological Evaluation of New Triazolo[1,5-a]Pyrimidine Derivatives as Highly Potent and Orally Active ABCB1 Modulators. Journal of medicinal chemistry 63 (24) (2020)

Bin Yu.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Bin Yu